Literature DB >> 32640451

Variations in the Referral Pattern for Genetic Counseling of Patients with Early-Onset Breast Cancer: A Population-Based Study in Southern Sweden.

Annelie Augustinsson1,2, Carolina Ellberg3,4, Ulf Kristoffersson5,6, Håkan Olsson3,4, Hans Ehrencrona5,6.   

Abstract

Swedish national breast cancer guidelines recommend that all women diagnosed with breast cancer (BC) at the age of 35 years or younger should be referred to their regional oncogenetic clinic for genetic counseling and testing, regardless of family history of cancer. The main objective of this study was to evaluate whether place of residence at BC diagnosis and treating hospital were associated with the fact that not all BC patients diagnosed at ≤35 years in the southern part of Sweden have attended genetic counseling and testing. Between 2000 and 2013, 279 women in the South Swedish Health Care Region were diagnosed with BC at ≤35 years. Information regarding place of residence at BC diagnosis, treating hospital, time of registration and first meeting at the Oncogenetic Clinic in Lund, and genetic testing was collected. With a follow-up period until August 2018, 64% were registered at the clinic (60% underwent genetic testing) and 36% were not. BC patients from 2 counties and from rural settings with a population of <10,000 inhabitants were significantly less likely to be registered at the clinic. Our results suggest that place of residence at BC diagnosis and treating hospital were associated with the probability of referral for genetic counseling and testing for women diagnosed with BC at ≤35 years in the South Swedish Health Care Region. We propose, as a generalizable finding, that further educational and outreach activities within the health care system and the community may be needed to ensure that all women diagnosed with early-onset BC receive proper genetic counseling.
© 2020 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  BRCA1; BRCA2; Breast cancer; Early-onset; Genetic counseling

Mesh:

Substances:

Year:  2020        PMID: 32640451      PMCID: PMC7592930          DOI: 10.1159/000508684

Source DB:  PubMed          Journal:  Public Health Genomics        ISSN: 1662-4246            Impact factor:   2.000


  22 in total

1.  BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.

Authors:  Shoshana M Rosenberg; Kathryn J Ruddy; Rulla M Tamimi; Shari Gelber; Lidia Schapira; Steven Come; Virginia F Borges; Bryce Larsen; Judy E Garber; Ann H Partridge
Journal:  JAMA Oncol       Date:  2016-06-01       Impact factor: 31.777

2.  First international consensus guidelines for breast cancer in young women (BCY1).

Authors:  Ann H Partridge; Olivia Pagani; Omalkhair Abulkhair; Stefan Aebi; Frédéric Amant; Hatem A Azim; Alberto Costa; Suzette Delaloge; Gloria Freilich; Oreste Davide Gentilini; Nadia Harbeck; Catherine M Kelly; Sibylle Loibl; Dror Meirow; Fedro Peccatori; Bella Kaufmann; Fatima Cardoso
Journal:  Breast       Date:  2014-04-24       Impact factor: 4.380

3.  Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer.

Authors:  Annelie Augustinsson; Carolina Ellberg; Ulf Kristoffersson; Åke Borg; Håkan Olsson
Journal:  Acta Oncol       Date:  2017-11-22       Impact factor: 4.089

Review 4.  Breast cancer genetics in young women: What do we know?

Authors:  Liliana Gómez-Flores-Ramos; Rosa María Álvarez-Gómez; Cynthia Villarreal-Garza; Talia Wegman-Ostrosky; Alejandro Mohar
Journal:  Mutat Res Rev Mutat Res       Date:  2017-08-25       Impact factor: 5.657

5.  Second international consensus guidelines for breast cancer in young women (BCY2).

Authors:  Shani Paluch-Shimon; Olivia Pagani; Ann H Partridge; Eran Bar-Meir; Lesley Fallowfield; Deborah Fenlon; Eitan Friedman; Karen Gelmon; Oreste Gentilini; James Geraghty; Nadia Harbeck; Stephen Higgins; Sibylle Loibl; Elizabeth Moser; Fedro Peccatori; Hila Raanani; Bella Kaufman; Fatima Cardoso
Journal:  Breast       Date:  2016-02-06       Impact factor: 4.380

6.  The effect of a celebrity health disclosure on demand for health care: trends in BRCA testing and subsequent health services use.

Authors:  Megan C Roberts; Stacie B Dusetzina
Journal:  J Community Genet       Date:  2017-03-15

Review 7.  Personalised medicine and population health: breast and ovarian cancer.

Authors:  Steven A Narod
Journal:  Hum Genet       Date:  2018-10-17       Impact factor: 4.132

8.  Rates of BRCA1/2 mutation testing among young survivors of breast cancer.

Authors:  Kenneth L Kehl; Chan Shen; Jennifer K Litton; Banu Arun; Sharon H Giordano
Journal:  Breast Cancer Res Treat       Date:  2015-12-26       Impact factor: 4.872

9.  Familial breast cancer: Genetic counseling over time, including patients´ expectations and initiators considering the Angelina Jolie effect.

Authors:  Christina Evers; Christine Fischer; Nicola Dikow; Sarah Schott
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

10.  SEOM clinical guidelines in Hereditary Breast and ovarian cancer.

Authors:  G Llort; I Chirivella; R Morales; R Serrano; A Beatriz Sanchez; A Teulé; E Lastra; J Brunet; J Balmaña; B Graña
Journal:  Clin Transl Oncol       Date:  2015-12-15       Impact factor: 3.405

View more
  1 in total

1.  Genetic testing in women with early-onset breast cancer: a Traceback pilot study.

Authors:  Annelie Augustinsson; Martin P Nilsson; Carolina Ellberg; Ulf Kristoffersson; Håkan Olsson; Hans Ehrencrona
Journal:  Breast Cancer Res Treat       Date:  2021-09-16       Impact factor: 4.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.